| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | retinoic acid-responsive element binding | 1.55e-04 | 7 | 55 | 2 | GO:0044323 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 1.67e-04 | 188 | 55 | 5 | GO:0005201 | |
| GeneOntologyMolecularFunction | benzodiazepine receptor activity | 4.03e-04 | 11 | 55 | 2 | GO:0008503 | |
| GeneOntologyMolecularFunction | growth factor binding | 8.97e-04 | 156 | 55 | 4 | GO:0019838 | |
| GeneOntologyMolecularFunction | GABA-gated chloride ion channel activity | 1.11e-03 | 18 | 55 | 2 | GO:0022851 | |
| GeneOntologyMolecularFunction | nuclear vitamin D receptor binding | 1.11e-03 | 18 | 55 | 2 | GO:0042809 | |
| GeneOntologyMolecularFunction | GABA-A receptor activity | 1.24e-03 | 19 | 55 | 2 | GO:0004890 | |
| GeneOntologyMolecularFunction | peptidoglycan binding | 1.24e-03 | 19 | 55 | 2 | GO:0042834 | |
| GeneOntologyMolecularFunction | oligosaccharide binding | 1.37e-03 | 20 | 55 | 2 | GO:0070492 | |
| GeneOntologyMolecularFunction | GABA receptor activity | 1.66e-03 | 22 | 55 | 2 | GO:0016917 | |
| GeneOntologyMolecularFunction | nuclear steroid receptor activity | 2.15e-03 | 25 | 55 | 2 | GO:0003707 | |
| GeneOntologyMolecularFunction | Notch binding | 2.50e-03 | 27 | 55 | 2 | GO:0005112 | |
| GeneOntologyBiologicalProcess | skeletal muscle tissue regeneration | 1.85e-05 | 59 | 55 | 4 | GO:0043403 | |
| GeneOntologyBiologicalProcess | detection of monosaccharide stimulus | 2.09e-05 | 3 | 55 | 2 | GO:0034287 | |
| GeneOntologyBiologicalProcess | detection of hexose stimulus | 2.09e-05 | 3 | 55 | 2 | GO:0009732 | |
| GeneOntologyBiologicalProcess | detection of carbohydrate stimulus | 2.09e-05 | 3 | 55 | 2 | GO:0009730 | |
| GeneOntologyBiologicalProcess | mitochondrial mRNA catabolic process | 2.09e-05 | 3 | 55 | 2 | GO:0000958 | |
| GeneOntologyBiologicalProcess | positive regulation of detection of glucose | 2.09e-05 | 3 | 55 | 2 | GO:2000972 | |
| GeneOntologyBiologicalProcess | regulation of detection of glucose | 2.09e-05 | 3 | 55 | 2 | GO:2000970 | |
| GeneOntologyBiologicalProcess | detection of glucose | 2.09e-05 | 3 | 55 | 2 | GO:0051594 | |
| GeneOntologyBiologicalProcess | mitochondrial RNA catabolic process | 1.04e-04 | 6 | 55 | 2 | GO:0000957 | |
| GeneOntologyBiologicalProcess | positive regulation of vitamin D receptor signaling pathway | 1.04e-04 | 6 | 55 | 2 | GO:0070564 | |
| GeneOntologyBiologicalProcess | tissue regeneration | 1.41e-04 | 99 | 55 | 4 | GO:0042246 | |
| GeneOntologyBiologicalProcess | response to symbiont | 1.93e-04 | 8 | 55 | 2 | GO:0009608 | |
| GeneOntologyBiologicalProcess | response to symbiotic bacterium | 1.93e-04 | 8 | 55 | 2 | GO:0009609 | |
| GeneOntologyBiologicalProcess | regulation of vitamin D receptor signaling pathway | 3.10e-04 | 10 | 55 | 2 | GO:0070562 | |
| GeneOntologyBiologicalProcess | negative regulation of keratinocyte differentiation | 3.10e-04 | 10 | 55 | 2 | GO:0045617 | |
| GeneOntologyBiologicalProcess | antiviral innate immune response | 4.50e-04 | 56 | 55 | 3 | GO:0140374 | |
| GeneOntologyBiologicalProcess | regulation of keratinocyte proliferation | 4.50e-04 | 56 | 55 | 3 | GO:0010837 | |
| GeneOntologyBiologicalProcess | vitamin D receptor signaling pathway | 4.53e-04 | 12 | 55 | 2 | GO:0070561 | |
| GeneOntologyBiologicalProcess | negative regulation of cellular response to oxidative stress | 4.53e-04 | 12 | 55 | 2 | GO:1900408 | |
| GeneOntologyBiologicalProcess | negative regulation of inflammatory response to wounding | 5.34e-04 | 13 | 55 | 2 | GO:0106015 | |
| GeneOntologyBiologicalProcess | cellular response to interleukin-12 | 5.34e-04 | 13 | 55 | 2 | GO:0071349 | |
| GeneOntologyCellularComponent | extracellular matrix | SNED1 EYS SRPX2 ADIPOQ CELA2A REG3G REG3A MUC5AC FBN3 HAPLN1 | 7.07e-06 | 656 | 55 | 10 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | SNED1 EYS SRPX2 ADIPOQ CELA2A REG3G REG3A MUC5AC FBN3 HAPLN1 | 7.26e-06 | 658 | 55 | 10 | GO:0030312 |
| GeneOntologyCellularComponent | extrinsic component of cytoplasmic side of plasma membrane | 4.33e-04 | 56 | 55 | 3 | GO:0031234 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 4.58e-04 | 530 | 55 | 7 | GO:0062023 | |
| GeneOntologyCellularComponent | GABA-A receptor complex | 1.13e-03 | 19 | 55 | 2 | GO:1902711 | |
| GeneOntologyCellularComponent | GABA receptor complex | 1.38e-03 | 21 | 55 | 2 | GO:1902710 | |
| Domain | hEGF | 1.31e-06 | 28 | 55 | 4 | PF12661 | |
| Domain | GABAAa_rcpt | 1.27e-04 | 6 | 55 | 2 | IPR001390 | |
| Domain | EGF_Ca-bd_CS | 1.90e-04 | 97 | 55 | 4 | IPR018097 | |
| Domain | EGF_CA | 2.06e-04 | 99 | 55 | 4 | PS01187 | |
| Domain | ASX_HYDROXYL | 2.14e-04 | 100 | 55 | 4 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 2.68e-04 | 106 | 55 | 4 | IPR000152 | |
| Domain | Retinoid-X_rcpt/HNF4 | 3.77e-04 | 10 | 55 | 2 | IPR000003 | |
| Domain | EGF_CA | 4.57e-04 | 122 | 55 | 4 | SM00179 | |
| Domain | Fol_N | 4.60e-04 | 11 | 55 | 2 | IPR003645 | |
| Domain | FOLN | 4.60e-04 | 11 | 55 | 2 | SM00274 | |
| Domain | EGF-like_Ca-bd_dom | 4.86e-04 | 124 | 55 | 4 | IPR001881 | |
| Domain | EGF | 5.16e-04 | 126 | 55 | 4 | PF00008 | |
| Domain | CCP | 5.39e-04 | 54 | 55 | 3 | SM00032 | |
| Domain | SUSHI | 6.00e-04 | 56 | 55 | 3 | PS50923 | |
| Domain | EGF_3 | 6.30e-04 | 235 | 55 | 5 | PS50026 | |
| Domain | EGF | 6.30e-04 | 235 | 55 | 5 | SM00181 | |
| Domain | Sushi_SCR_CCP_dom | 6.32e-04 | 57 | 55 | 3 | IPR000436 | |
| Domain | EGF-like_dom | 8.17e-04 | 249 | 55 | 5 | IPR000742 | |
| Domain | EGF_1 | 9.09e-04 | 255 | 55 | 5 | PS00022 | |
| Domain | EGF-like_CS | 1.01e-03 | 261 | 55 | 5 | IPR013032 | |
| Domain | EGF_2 | 1.08e-03 | 265 | 55 | 5 | PS01186 | |
| Domain | Kringle | 1.13e-03 | 17 | 55 | 2 | IPR000001 | |
| Domain | Kringle_CS | 1.13e-03 | 17 | 55 | 2 | IPR018056 | |
| Domain | KRINGLE_2 | 1.13e-03 | 17 | 55 | 2 | PS50070 | |
| Domain | Kringle | 1.13e-03 | 17 | 55 | 2 | PF00051 | |
| Domain | KRINGLE_1 | 1.13e-03 | 17 | 55 | 2 | PS00021 | |
| Domain | KR | 1.13e-03 | 17 | 55 | 2 | SM00130 | |
| Domain | KAZAL_1 | 1.26e-03 | 18 | 55 | 2 | PS00282 | |
| Domain | Kazal_1 | 1.89e-03 | 22 | 55 | 2 | PF00050 | |
| Domain | GABAA/Glycine_rcpt | 2.07e-03 | 23 | 55 | 2 | IPR006028 | |
| Domain | - | 2.93e-03 | 97 | 55 | 3 | 3.10.100.10 | |
| Domain | C-type_lectin-like/link | 3.10e-03 | 99 | 55 | 3 | IPR016186 | |
| Domain | CTDL_fold | 3.86e-03 | 107 | 55 | 3 | IPR016187 | |
| Domain | Kringle-like | 3.99e-03 | 32 | 55 | 2 | IPR013806 | |
| Domain | Kazal_2 | 5.03e-03 | 36 | 55 | 2 | PF07648 | |
| Domain | C-type_lectin_CS | 7.12e-03 | 43 | 55 | 2 | IPR018378 | |
| Domain | Neurotransmitter_ion_chnl_CS | 7.77e-03 | 45 | 55 | 2 | IPR018000 | |
| Domain | Neur_chan_memb | 8.11e-03 | 46 | 55 | 2 | PF02932 | |
| Domain | zf-C4 | 8.11e-03 | 46 | 55 | 2 | PF00105 | |
| Domain | Znf_hrmn_rcpt | 8.11e-03 | 46 | 55 | 2 | IPR001628 | |
| Domain | Nuclear_hrmn_rcpt | 8.11e-03 | 46 | 55 | 2 | IPR001723 | |
| Domain | NUCLEAR_REC_DBD_2 | 8.11e-03 | 46 | 55 | 2 | PS51030 | |
| Domain | NUCLEAR_REC_DBD_1 | 8.11e-03 | 46 | 55 | 2 | PS00031 | |
| Domain | KAZAL | 8.11e-03 | 46 | 55 | 2 | SM00280 | |
| Domain | ZnF_C4 | 8.11e-03 | 46 | 55 | 2 | SM00399 | |
| Domain | Neur_chan_LBD | 8.46e-03 | 47 | 55 | 2 | PF02931 | |
| Domain | - | 8.46e-03 | 47 | 55 | 2 | 1.10.565.10 | |
| Domain | NEUROTR_ION_CHANNEL | 8.46e-03 | 47 | 55 | 2 | PS00236 | |
| Domain | Neurotrans-gated_channel_TM | 8.46e-03 | 47 | 55 | 2 | IPR006029 | |
| Domain | - | 8.46e-03 | 47 | 55 | 2 | 2.70.170.10 | |
| Domain | Neur_channel | 8.46e-03 | 47 | 55 | 2 | IPR006201 | |
| Domain | Neur_chan_lig-bd | 8.46e-03 | 47 | 55 | 2 | IPR006202 | |
| Domain | HOLI | 8.81e-03 | 48 | 55 | 2 | SM00430 | |
| Domain | Nucl_hrmn_rcpt_lig-bd | 8.81e-03 | 48 | 55 | 2 | IPR000536 | |
| Domain | Hormone_recep | 8.81e-03 | 48 | 55 | 2 | PF00104 | |
| Pathway | WP_VITAMIN_A_AND_CAROTENOID_METABOLISM | 9.32e-06 | 43 | 44 | 4 | M39554 | |
| Pathway | WP_RETINOL_METABOLISM | 1.02e-05 | 44 | 44 | 4 | MM15851 | |
| Pathway | KEGG_MEDICUS_VARIANT_PAX8_PPARG_FUSION_TO_PPARG_MEDIATED_TRANSCRIPTION | 9.46e-05 | 5 | 44 | 2 | M49023 | |
| Pathway | REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_LINKED_TO_GLUCONEOGENESIS | 9.46e-05 | 5 | 44 | 2 | M29812 | |
| Pathway | REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_TO_LIMIT_CHOLESTEROL_UPTAKE | 9.46e-05 | 5 | 44 | 2 | M29791 | |
| Pathway | REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_LINKED_TO_TRIGLYCERIDE_LIPOLYSIS_IN_ADIPOSE | 9.46e-05 | 5 | 44 | 2 | M29792 | |
| Pathway | REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_TO_CONTROL_BILE_ACID_HOMEOSTASIS | 1.42e-04 | 6 | 44 | 2 | MM15663 | |
| Pathway | WP_VITAMIN_A1_AND_A5X_PATHWAYS | 1.42e-04 | 6 | 44 | 2 | M48097 | |
| Pathway | WP_NUCLEAR_RECEPTORS | 2.22e-04 | 38 | 44 | 3 | M39657 | |
| Pathway | WP_NUCLEAR_RECEPTORS | 2.22e-04 | 38 | 44 | 3 | MM15865 | |
| Pathway | BIOCARTA_VOBESITY_PATHWAY | 2.63e-04 | 8 | 44 | 2 | MM1542 | |
| Pathway | BIOCARTA_VOBESITY_PATHWAY | 2.63e-04 | 8 | 44 | 2 | M22017 | |
| Pathway | REACTOME_SIGNALING_BY_RETINOIC_ACID | 3.21e-04 | 43 | 44 | 3 | M27443 | |
| Pathway | BIOCARTA_FLUMAZENIL_PATHWAY | 3.38e-04 | 9 | 44 | 2 | M22034 | |
| Pathway | REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_TO_CONTROL_BILE_ACID_HOMEOSTASIS | 3.38e-04 | 9 | 44 | 2 | M29809 | |
| Pathway | REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_LINKED_TO_LIPOGENESIS | 3.38e-04 | 9 | 44 | 2 | M29789 | |
| Pathway | KEGG_MEDICUS_REFERENCE_THYROID_HORMONE_SIGNALING_PATHWAY | 3.38e-04 | 9 | 44 | 2 | M47629 | |
| Pathway | WP_VITAMIN_D_METABOLISM | 4.22e-04 | 10 | 44 | 2 | M39352 | |
| Pathway | BIOCARTA_GABA_PATHWAY | 4.22e-04 | 10 | 44 | 2 | MM1401 | |
| Pathway | BIOCARTA_GABA_PATHWAY | 4.22e-04 | 10 | 44 | 2 | M477 | |
| Pathway | REACTOME_SIGNALING_BY_RETINOIC_ACID | 4.73e-04 | 49 | 44 | 3 | MM15186 | |
| Pathway | REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING | 7.27e-04 | 13 | 44 | 2 | MM15622 | |
| Pathway | REACTOME_GABA_RECEPTOR_ACTIVATION | 8.57e-04 | 60 | 44 | 3 | M976 | |
| Pathway | REACTOME_GABA_RECEPTOR_ACTIVATION | 8.57e-04 | 60 | 44 | 3 | MM15708 | |
| Pathway | WP_PPAR_SIGNALING | 1.18e-03 | 67 | 44 | 3 | M39553 | |
| Pathway | KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY | 1.18e-03 | 67 | 44 | 3 | M10462 | |
| Pathway | KEGG_PPAR_SIGNALING_PATHWAY | 1.29e-03 | 69 | 44 | 3 | M13088 | |
| Pathway | WP_PPAR_SIGNALING_PATHWAY | 1.52e-03 | 73 | 44 | 3 | MM15995 | |
| Pathway | WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3 | 1.64e-03 | 75 | 44 | 3 | M39568 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 1.93e-03 | 21 | 44 | 2 | MM15706 | |
| Pubmed | 7.67e-10 | 118 | 55 | 7 | 16971476 | ||
| Pubmed | 4.46e-07 | 10 | 55 | 3 | 21681751 | ||
| Pubmed | Dlx6 regulates molecular properties of the striatum and central nucleus of the amygdala. | 1.06e-06 | 13 | 55 | 3 | 21452241 | |
| Pubmed | RXR alpha mutant mice establish a genetic basis for vitamin A signaling in heart morphogenesis. | 2.46e-06 | 2 | 55 | 2 | 7926783 | |
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 8795446 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 17998566 | ||
| Pubmed | Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host disease. | 2.46e-06 | 2 | 55 | 2 | 21979939 | |
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 32352211 | ||
| Pubmed | Tyk2 mediates effects of urokinase on human vascular smooth muscle cell growth. | 2.46e-06 | 2 | 55 | 2 | 17548050 | |
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 24810760 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 29544958 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 8780715 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 20798333 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 22316320 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 21187123 | ||
| Pubmed | Regulation of C-type lectin antimicrobial activity by a flexible N-terminal prosegment. | 2.46e-06 | 2 | 55 | 2 | 19095652 | |
| Pubmed | Symbiotic bacteria direct expression of an intestinal bactericidal lectin. | 2.46e-06 | 2 | 55 | 2 | 16931762 | |
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 33246082 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 26867181 | ||
| Pubmed | Endogenous retinoid X receptor ligands in mouse hematopoietic cells. | 2.46e-06 | 2 | 55 | 2 | 29089448 | |
| Pubmed | Salmonella-induced mucosal lectin RegIIIβ kills competing gut microbiota. | 2.46e-06 | 2 | 55 | 2 | 21694778 | |
| Pubmed | Recombinant Reg3α protein protects against experimental acute pancreatitis in mice. | 2.46e-06 | 2 | 55 | 2 | 26683606 | |
| Pubmed | Three retinoid X receptor gene polymorphisms in plaque psoriasis and psoriasis guttata. | 2.46e-06 | 2 | 55 | 2 | 17341859 | |
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 7679928 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 32560820 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 16199515 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 30931933 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 8076648 | ||
| Pubmed | A transcriptionally silent RXRalpha supports early embryonic morphogenesis and heart development. | 2.46e-06 | 2 | 55 | 2 | 19255444 | |
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 25938566 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 10564727 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 21245462 | ||
| Pubmed | 5.64e-06 | 22 | 55 | 3 | 10753524 | ||
| Pubmed | 6.48e-06 | 23 | 55 | 3 | 28190640 | ||
| Pubmed | Pancreatic STAT3 protects mice against caerulein-induced pancreatitis via PAP1 induction. | 7.36e-06 | 3 | 55 | 2 | 23064197 | |
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 35915986 | ||
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 14660681 | ||
| Pubmed | Unique response pathways are established by allosteric interactions among nuclear hormone receptors. | 7.36e-06 | 3 | 55 | 2 | 7758108 | |
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 9727070 | ||
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 7831303 | ||
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 22940118 | ||
| Pubmed | Investigation of autism and GABA receptor subunit genes in multiple ethnic groups. | 7.36e-06 | 3 | 55 | 2 | 16770606 | |
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 19188585 | ||
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 7990953 | ||
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 27184385 | ||
| Pubmed | Characterization of three RXR genes that mediate the action of 9-cis retinoic acid. | 7.36e-06 | 3 | 55 | 2 | 1312497 | |
| Pubmed | Multifunctional enhancers regulate mouse and human vitamin D receptor gene transcription. | 7.36e-06 | 3 | 55 | 2 | 19897601 | |
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 18375961 | ||
| Pubmed | Detection of retinoid X receptors using specific monoclonal and polyclonal antibodies. | 7.36e-06 | 3 | 55 | 2 | 7980510 | |
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 36012669 | ||
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 10049761 | ||
| Pubmed | Immunohistochemical detection of the retinoid X receptors alpha, beta, and gamma in human prostate. | 7.36e-06 | 3 | 55 | 2 | 12514092 | |
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 31362033 | ||
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 11053444 | ||
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 30106382 | ||
| Pubmed | Retinoid X receptors: X-ploring their (patho)physiological functions. | 7.36e-06 | 3 | 55 | 2 | 15608692 | |
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 8034312 | ||
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 10329612 | ||
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 33923774 | ||
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 8631847 | ||
| Pubmed | Retinoid receptors trigger neuritogenesis in retinal degenerations. | 7.36e-06 | 3 | 55 | 2 | 21940995 | |
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 11839661 | ||
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 24027285 | ||
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 18217139 | ||
| Pubmed | Myocardial healing requires Reg3β-dependent accumulation of macrophages in the ischemic heart. | 7.36e-06 | 3 | 55 | 2 | 25751817 | |
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 8799145 | ||
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 34099862 | ||
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 27143303 | ||
| Pubmed | 1.47e-05 | 4 | 55 | 2 | 8670810 | ||
| Pubmed | 1.47e-05 | 4 | 55 | 2 | 1310259 | ||
| Pubmed | 1.47e-05 | 4 | 55 | 2 | 12719789 | ||
| Pubmed | Retinoic acid biosynthetic activity and retinoid receptors in the olfactory mucosa of adult mice. | 1.47e-05 | 4 | 55 | 2 | 10079186 | |
| Pubmed | 1.47e-05 | 4 | 55 | 2 | 8524212 | ||
| Pubmed | 1.47e-05 | 4 | 55 | 2 | 23147030 | ||
| Pubmed | Intestinally secreted C-type lectin Reg3b attenuates salmonellosis but not listeriosis in mice. | 1.47e-05 | 4 | 55 | 2 | 22252863 | |
| Pubmed | 1.47e-05 | 4 | 55 | 2 | 26355550 | ||
| Pubmed | 1.47e-05 | 4 | 55 | 2 | 22727489 | ||
| Pubmed | Retinoids activate RXR/CAR-mediated pathway and induce CYP3A. | 1.47e-05 | 4 | 55 | 2 | 19686701 | |
| Pubmed | Retinoid X receptors are essential for early mouse development and placentogenesis. | 1.47e-05 | 4 | 55 | 2 | 9892670 | |
| Pubmed | Coordinated age-dependent and pancreatic-specific expression of mouse Reg2Reg3α, and Reg3β genes. | 1.47e-05 | 4 | 55 | 2 | 21410322 | |
| Pubmed | 1.47e-05 | 4 | 55 | 2 | 9348290 | ||
| Pubmed | Retinoid X receptors orchestrate osteoclast differentiation and postnatal bone remodeling. | 1.47e-05 | 4 | 55 | 2 | 25574839 | |
| Pubmed | 1.47e-05 | 4 | 55 | 2 | 10361124 | ||
| Pubmed | Retinoic X receptor subtypes exert differential effects on the regulation of Trh transcription. | 1.47e-05 | 4 | 55 | 2 | 23896434 | |
| Pubmed | 1.47e-05 | 4 | 55 | 2 | 19343564 | ||
| Pubmed | 1.47e-05 | 4 | 55 | 2 | 10594021 | ||
| Pubmed | 1.47e-05 | 4 | 55 | 2 | 9804293 | ||
| Pubmed | Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. | 1.47e-05 | 4 | 55 | 2 | 7481822 | |
| Pubmed | 1.47e-05 | 4 | 55 | 2 | 26404002 | ||
| Pubmed | Reg3β deficiency impairs pancreatic tumor growth by skewing macrophage polarization. | 1.47e-05 | 4 | 55 | 2 | 23867474 | |
| Pubmed | 1.47e-05 | 4 | 55 | 2 | 22723890 | ||
| Pubmed | 1.47e-05 | 4 | 55 | 2 | 32246014 | ||
| Pubmed | 1.47e-05 | 4 | 55 | 2 | 7967725 | ||
| Pubmed | 1.47e-05 | 4 | 55 | 2 | 36240758 | ||
| Pubmed | 1.47e-05 | 4 | 55 | 2 | 12091471 | ||
| Pubmed | 1.47e-05 | 4 | 55 | 2 | 10611353 | ||
| Pubmed | 1.47e-05 | 4 | 55 | 2 | 12549917 | ||
| Pubmed | 1.47e-05 | 4 | 55 | 2 | 28415799 | ||
| Pubmed | 1.47e-05 | 4 | 55 | 2 | 10767532 | ||
| Pubmed | 1.80e-05 | 32 | 55 | 3 | 17270348 | ||
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 2.50e-04 | 57 | 39 | 3 | 1179 | |
| GeneFamily | Gamma-aminobutyric acid type A receptor subunits | 7.58e-04 | 19 | 39 | 2 | 563 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 3.53e-03 | 41 | 39 | 2 | 1298 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 4.09e-03 | 718 | 39 | 6 | 28 | |
| GeneFamily | Nuclear hormone receptors | 5.00e-03 | 49 | 39 | 2 | 71 | |
| Coexpression | NABA_MATRISOME | SNED1 EYS SRPX2 ADIPOQ CELA2A REG3G REG3A PAPPA PLAU HCFC2 MUC5AC FBN3 HAPLN1 | 1.48e-07 | 1026 | 55 | 13 | M5889 |
| Coexpression | GSE26343_UNSTIM_VS_LPS_STIM_NFAT5_KO_MACROPHAGE_UP | 3.67e-06 | 198 | 55 | 6 | M8649 | |
| Coexpression | NABA_MATRISOME | SNED1 SRPX2 ADIPOQ CELA2A REG3G REG3A PAPPA PLAU HCFC2 MUC5AC HAPLN1 | 6.53e-06 | 1008 | 55 | 11 | MM17056 |
| Coexpression | URS_ADIPOCYTE_DIFFERENTIATION_UP | 1.14e-05 | 66 | 55 | 4 | M15476 | |
| Coexpression | NABA_CORE_MATRISOME | 2.38e-05 | 275 | 55 | 6 | M5884 | |
| Coexpression | YAO_HOXA10_TARGETS_VIA_PROGESTERONE_UP | 4.05e-05 | 91 | 55 | 4 | MM622 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 5.71e-05 | 196 | 55 | 5 | M3008 | |
| Coexpression | GSE41176_WT_VS_TAK1_KO_UNSTIM_BCELL_DN | 6.13e-05 | 199 | 55 | 5 | M9941 | |
| Coexpression | KONDO_EZH2_TARGETS | 1.19e-04 | 229 | 55 | 5 | M5301 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.13e-08 | 176 | 55 | 6 | 60740f676db5d259ef3046bd5bc7b7b14924ecee | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.28e-07 | 190 | 55 | 6 | 3f22c118d552345f731d4d49f0bcb5765d93de3b | |
| ToppCell | Fibroblasts-CD34+_Fibroblasts|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.49e-07 | 195 | 55 | 6 | c6b5249ac8714b1b701cde31d00ab53f28355c36 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.63e-07 | 198 | 55 | 6 | 09be07ebfc3e49c3858e9b74605b69cf4fc28b56 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.03e-06 | 182 | 55 | 5 | b54ae650c04dfd0759c5f5e752b9bf684dd36516 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.37e-06 | 186 | 55 | 5 | 948815663c212c4311329d503b5991cbbbff9808 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E-|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.37e-06 | 186 | 55 | 5 | 1bac7825c2fe3e6cdff65026b09b9ccaa40fa27f | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.37e-06 | 186 | 55 | 5 | 59db239f1864a5d4f1570c93219dbd7ac5b6db35 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.55e-06 | 188 | 55 | 5 | 8de5a07301f9b5984680c873e5a92395b5ed3dd3 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.73e-06 | 190 | 55 | 5 | e58e4b6fbeb4368f738adac67ec10879c0966f0f | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.93e-06 | 192 | 55 | 5 | bf1943715085c4124b1675888b0615c9500ec888 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.03e-06 | 193 | 55 | 5 | c4b22b62f3cc7bf0ec0eba76e1504c236290bbc9 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.13e-06 | 194 | 55 | 5 | 52aebb0b563e2c2058e7f0554ae870e47692b163 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.13e-06 | 194 | 55 | 5 | bd06e2b8d8c06cddf2e4f58849b86e09013acae1 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.79e-06 | 200 | 55 | 5 | 1276bfa911fddada4235e12e3081baa53164574b | |
| ToppCell | mild_COVID-19_(asymptomatic)-NK_CD56bright|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 3.64e-05 | 151 | 55 | 4 | 2470162f4b56bc505db166a6eb0fa54847759df8 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.64e-05 | 151 | 55 | 4 | 75c068b3e3aae5f9ba64d5fa5d1e2105a60e4293 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 4.03e-05 | 155 | 55 | 4 | 105d59d8a1bb8cb37eef2c1767d737b2108ac7c5 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.13e-05 | 156 | 55 | 4 | d411116d54add2d4fe649a97ac54cb94c085312f | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 4.45e-05 | 159 | 55 | 4 | 7f29f9dcf25ffa1822b137c571e9ac16defc6292 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.79e-05 | 162 | 55 | 4 | 373513f9d0e5007b2e10a8b78d4909dcce9e3b62 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 5.39e-05 | 167 | 55 | 4 | 9a84f45345c75f2c8ff38a04245aadee2a26a240 | |
| ToppCell | TCGA-Pancreas|World / Sample_Type by Project: Shred V9 | 5.51e-05 | 168 | 55 | 4 | 279d5fcf9bd3f56ab560e37eed6fb3bd57dd93de | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 5.64e-05 | 169 | 55 | 4 | c135d7ae0490d0024e0f4bd8c4ad42f6674a61da | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.64e-05 | 169 | 55 | 4 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-2_VIP_RPL41P3|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.77e-05 | 170 | 55 | 4 | 31e3f57673c99f4d8ef30faa9c40e5f7f5bf6460 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_low-phase|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.18e-05 | 173 | 55 | 4 | 506efcaa5afd6ed5e565c4c4def6a4505fea97c5 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD8-Tnaive/CM_CD8|Liver / Manually curated celltypes from each tissue | 6.32e-05 | 174 | 55 | 4 | 03918ca51ae3b4c9c1a74769b08ea23f518286ba | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.60e-05 | 176 | 55 | 4 | 12bccbd56742fcfe19749da802ea1cf62ec9a872 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.90e-05 | 178 | 55 | 4 | 415a02ad14df9deba988990118b00fb84ee524a8 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.90e-05 | 178 | 55 | 4 | 3c973aac16988e88f5677d3d695dd772ccfd6570 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_SST_CXCL14|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.05e-05 | 179 | 55 | 4 | c7afbd10072d36a35cd20ae73670d76b9cefd22d | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.36e-05 | 181 | 55 | 4 | bd7e9437839bca543ca5945df43d6525e6a312a8 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.36e-05 | 181 | 55 | 4 | cf8f7798559fedf91ee21b3ebc93171cfd14f89f | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.52e-05 | 182 | 55 | 4 | 7dc61e901428cea04f00ebb0939a44d21a6145c6 | |
| ToppCell | droplet-Pancreas-PANCREAS|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.52e-05 | 182 | 55 | 4 | ecb8c1d0b9e0766fae4dd2568456eb78a3cfce9a | |
| ToppCell | droplet-Pancreas-PANCREAS-30m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.52e-05 | 182 | 55 | 4 | cf1ccfc4709364763fa73e60d5f2c05ce268d5c1 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.52e-05 | 182 | 55 | 4 | a8cc56f32efe180e8fb5d69dbe606a794b3db700 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.52e-05 | 182 | 55 | 4 | 420a8fd30543e37a66ba0786215d056d308660d0 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.52e-05 | 182 | 55 | 4 | 3dfa9187e9d2bab1d199079d29209c4648220ada | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-T_cells|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.52e-05 | 182 | 55 | 4 | 09d0793245d3d77ab5fc384c0b62637f736da50b | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-early_osteoblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 7.68e-05 | 183 | 55 | 4 | 27a57cd8ea924420e182f3d72f5b29b00dea8fa0 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.68e-05 | 183 | 55 | 4 | 04d3cc76038b8192c915f1c08c3e26f2ad3b3779 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.68e-05 | 183 | 55 | 4 | e3ffef2b57dc5b96466dccc9cd54ba326ccf378a | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.85e-05 | 184 | 55 | 4 | 2ba98708dfd7f1b2a661578a334684094ff453ad | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.01e-05 | 185 | 55 | 4 | 16e9ccea0e3b95d90dc48ef74206c805681dac0b | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.01e-05 | 185 | 55 | 4 | 739260f8abebaf10a5cc49d91726278579e26170 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Epcam____podocyte-3|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.18e-05 | 186 | 55 | 4 | 29c79b5a29907d4f3f87ad2ca04840c0f15b7d4e | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.18e-05 | 186 | 55 | 4 | 77592a6397b44b2b59a4fc39d7224dd95343efe6 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus_-18m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.18e-05 | 186 | 55 | 4 | 28699e3574d3a183190bdb6c5db2219167d41579 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus_-18m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.18e-05 | 186 | 55 | 4 | f3345fad9559ec222062a6f516b9d3f815d98acf | |
| ToppCell | facs-Brain_Myeloid-Hippocampus_-18m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.18e-05 | 186 | 55 | 4 | 77baa0075e53ccb654a561e3289eba41deab8561 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus_|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.18e-05 | 186 | 55 | 4 | eb1d1941cd6e4d9f0655aff3ba8df3c29c06b3a2 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus_-18m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.18e-05 | 186 | 55 | 4 | 06e6e805f90d92c870f36b79fa0749988a4595bb | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.35e-05 | 187 | 55 | 4 | 77886f99c229610abd28c4c370d2c7d1536c9782 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.52e-05 | 188 | 55 | 4 | eea652bab161f19148a883e7e3fe2523b36b3cea | |
| ToppCell | 15-Distal-Epithelial-Secretory_progenitor|Distal / Age, Tissue, Lineage and Cell class | 8.52e-05 | 188 | 55 | 4 | 9a64fb07de611de38d6f24673feb3b81a5e85384 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.52e-05 | 188 | 55 | 4 | 3139540a656c0436b2123ea50741ff8d00112165 | |
| ToppCell | facs-Kidney-nan-3m-Mesenchymal-mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.70e-05 | 189 | 55 | 4 | a5306561026e4dfcc39beeb785e5108ac595d136 | |
| ToppCell | facs-Kidney-nan-3m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.70e-05 | 189 | 55 | 4 | 381058f55908f84375b54601d617389ef43ab855 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.70e-05 | 189 | 55 | 4 | 7659c7bbd58ee959a159294fb8d17317bbcc5681 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.70e-05 | 189 | 55 | 4 | 979b7fa947538aa7ca4a219263da2575869a2caa | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.70e-05 | 189 | 55 | 4 | 78cf414b98bcb19deb934409acddaad1cd51b67f | |
| ToppCell | facs-Kidney-nan-3m-Mesenchymal-mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.70e-05 | 189 | 55 | 4 | 302b950a6ad578f8aeff7ea6fd15fe631225287d | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.88e-05 | 190 | 55 | 4 | 8aea807a2bcf0b653b4de6202b6ecb0f0683cc2e | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.88e-05 | 190 | 55 | 4 | 305fbef734c350cfbf786ca7ff6e07093aab56ea | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.88e-05 | 190 | 55 | 4 | 39ab890104b4264c68a968f920f4ccd84f0bc681 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 9.06e-05 | 191 | 55 | 4 | 60ff989fe99d243a3d52955223680cdd1f1917a4 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.06e-05 | 191 | 55 | 4 | ca5669bd6f4a17471acae3eb229f845cc2e08efa | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|World / Lineage, Cell type, age group and donor | 9.06e-05 | 191 | 55 | 4 | d3733c8c4bda70c4390e5601fdda6188a64be944 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.06e-05 | 191 | 55 | 4 | fa50a3c7ff86e1ee07100da1ace0b0fa1b0ab26b | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 9.25e-05 | 192 | 55 | 4 | d0649410cf5eacdb0c1dce70e37c7473ef5fddfa | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway-epi_proximal_progenitor2_(4)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 9.25e-05 | 192 | 55 | 4 | c15841f35e24d6ef6ce2a9a6dc62e66efdc3d9d5 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.25e-05 | 192 | 55 | 4 | 67d6230e32d446dcb12047fae2c3f1faa80dd720 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.43e-05 | 193 | 55 | 4 | 4979862c0c16e6b4baa4c79894f1d237c861f5a5 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.43e-05 | 193 | 55 | 4 | 9f9eb241b0b82a6f12de6921c3acf6fed7cf65bb | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.43e-05 | 193 | 55 | 4 | e74fdc8718fe0933e1f4dd3fe37e2134983b99b6 | |
| ToppCell | droplet-Tongue-nan-3m-Epithelial-basal_cell|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.62e-05 | 194 | 55 | 4 | 1eef012e53e43c4f4f6968baac3cc28727c4a9b5 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.62e-05 | 194 | 55 | 4 | e5990880961d2469759ce4b3b20ae93ace3ebd1f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.62e-05 | 194 | 55 | 4 | 02a9cc821c2b14aa7d0e55661a5fab66364474e1 | |
| ToppCell | COVID-19-Heart-CM_1|Heart / Disease (COVID-19 only), tissue and cell type | 9.82e-05 | 195 | 55 | 4 | f1ef50331eda8f1239dba6ea970df4eaccf032f1 | |
| ToppCell | droplet-Tongue-nan-3m-Epithelial-basal_cell_of_epidermis|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.82e-05 | 195 | 55 | 4 | a31a8c0e8e666acfc6737fa2c54ebd6f35605520 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.00e-04 | 196 | 55 | 4 | 85507488f83d8f71b3ee2ad5e5aa0b6ad6193873 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.00e-04 | 196 | 55 | 4 | 7af6c5147ac859353504d19727dbe24f63a29dd4 | |
| ToppCell | Mild/Remission|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.00e-04 | 196 | 55 | 4 | 71603a3b7df40eb3f267345f55e44a812fea7926 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma-early_osteoblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.02e-04 | 197 | 55 | 4 | 2ca5ebb708935a90b12b8e98a22ae2d664ed002e | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Deep_Layer|World / Primary Cells by Cluster | 1.02e-04 | 197 | 55 | 4 | 41e823b14697827f657b13adb3afa581bd91a9cb | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.02e-04 | 197 | 55 | 4 | ab5d3ebc73bd7cfc64381d14b92878b370205186 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.02e-04 | 197 | 55 | 4 | b11a5d909942a4299cbc0b27332b1a3f66f3bccd | |
| ToppCell | Bronchial-10x5prime-Stromal-Mesofibroblastic-Mesothelia|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.02e-04 | 197 | 55 | 4 | 26888af95a7cc082a1f1218af35b1f07cb9436ed | |
| ToppCell | Bronchial-10x5prime-Stromal-Mesofibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.02e-04 | 197 | 55 | 4 | 438de7f0d35d81d5f5e41dcef7b2c54b6da03df4 | |
| ToppCell | Caecum-T_cell-Tcm|T_cell / Region, Cell class and subclass | 1.04e-04 | 198 | 55 | 4 | f889ee80c641540fd8db9eaefcd16aa51ddb2c01 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_IV-2|World / Primary Cells by Cluster | 1.06e-04 | 199 | 55 | 4 | f09b40245d3d826275bbe5f508dedccc75a911bd | |
| ToppCell | Mild/Remission-B_naive-9|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.06e-04 | 199 | 55 | 4 | e9af3c6a05f435ac8d7066f54feb653012b51ffb | |
| ToppCell | Caecum-(1)_T_cell-(14)_Tcm|Caecum / shred on region, Cell_type, and subtype | 1.06e-04 | 199 | 55 | 4 | 0f89426e8dec0cbe78f6c55caaa196daf0eaf66a | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_IV|World / Primary Cells by Cluster | 1.06e-04 | 199 | 55 | 4 | e45448ec4db8875c8aaa9aad109a10e2905a4226 | |
| ToppCell | Caecum-T_cell-Tcm|Caecum / Region, Cell class and subclass | 1.06e-04 | 199 | 55 | 4 | cab97db995a7d7df3b8f0511139ef0fe65ee55b9 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Fibroblastic-Fibro_peribronchial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.06e-04 | 199 | 55 | 4 | e9009eee7f77b9c9917f8e0e723001d9e76eb553 | |
| ToppCell | Mild/Remission-B_naive-9|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.06e-04 | 199 | 55 | 4 | 0451b1536be3725a520bfdd2b3dff133bea812e8 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_2(LAMP5)-LCP2--L1-4|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.08e-04 | 200 | 55 | 4 | f268cb1bb047e88913a828614b0a77871f5f8814 | |
| Computational | Genes in the cancer module 484. | 2.31e-04 | 42 | 31 | 3 | MODULE_484 | |
| Drug | Phthalylsulfathiazole [85-73-4]; Up 200; 10uM; PC3; HT_HG-U133A | 7.92e-06 | 197 | 55 | 6 | 4653_UP | |
| Drug | Deptropine citrate [2169-75-7]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 8.39e-06 | 199 | 55 | 6 | 5543_UP | |
| Drug | phenazepam | 1.06e-05 | 18 | 55 | 3 | CID000040113 | |
| Drug | Bexarotene | 1.72e-05 | 3 | 55 | 2 | DB00307 | |
| Drug | 2-hydroxyphytanic acid | 1.72e-05 | 3 | 55 | 2 | ctd:C002585 | |
| Drug | AC1O5SBP | 1.72e-05 | 3 | 55 | 2 | CID006439746 | |
| Drug | nonylamine | 1.72e-05 | 3 | 55 | 2 | CID000016214 | |
| Drug | beta-CCE | 2.95e-05 | 25 | 55 | 3 | CID000105078 | |
| Drug | AGN 190727 | 3.43e-05 | 4 | 55 | 2 | CID006439768 | |
| Drug | 7-methoxycitronellal | 5.70e-05 | 5 | 55 | 2 | CID000019223 | |
| Drug | 7-methoxycitronellic acid | 5.70e-05 | 5 | 55 | 2 | CID000171516 | |
| Drug | 13,14-dihydroretinol | 5.70e-05 | 5 | 55 | 2 | CID000446798 | |
| Drug | Lorazepam | 5.70e-05 | 5 | 55 | 2 | ctd:D008140 | |
| Drug | T0070907 | 5.72e-05 | 31 | 55 | 3 | CID002777391 | |
| Drug | CD367 | 6.91e-05 | 33 | 55 | 3 | CID000119342 | |
| Drug | Alitretinoin | 8.54e-05 | 6 | 55 | 2 | DB00523 | |
| Drug | Meprobamate | 8.54e-05 | 6 | 55 | 2 | DB00371 | |
| Drug | Adapalene | 8.54e-05 | 6 | 55 | 2 | DB00210 | |
| Drug | triphenyltin hydroxide | 8.54e-05 | 6 | 55 | 2 | ctd:C007567 | |
| Drug | Methoprene | 8.54e-05 | 6 | 55 | 2 | ctd:D008726 | |
| Drug | Etretinate | 8.54e-05 | 6 | 55 | 2 | DB00926 | |
| Drug | zaleplon | 8.54e-05 | 6 | 55 | 2 | ctd:C085665 | |
| Drug | Ro 41-5253 | 9.78e-05 | 37 | 55 | 3 | CID005312120 | |
| Drug | Butylparaben [94-26-8]; Up 200; 20.6uM; PC3; HT_HG-U133A | 1.08e-04 | 195 | 55 | 5 | 4647_UP | |
| Drug | 3-Acetylcoumarin [3949-36-8]; Up 200; 21.2uM; PC3; HT_HG-U133A | 1.10e-04 | 196 | 55 | 5 | 4664_UP | |
| Drug | Diloxanide furoate [3736-81-0]; Up 200; 12.2uM; HL60; HT_HG-U133A | 1.13e-04 | 197 | 55 | 5 | 3062_UP | |
| Drug | Rapamycin; Down 200; 0.1uM; HL60; HT_HG-U133A | 1.13e-04 | 197 | 55 | 5 | 2702_DN | |
| Drug | Troleandomycin [2751-09-9]; Up 200; 5uM; MCF7; HT_HG-U133A | 1.16e-04 | 198 | 55 | 5 | 1465_UP | |
| Drug | Acitretin | 1.19e-04 | 7 | 55 | 2 | DB00459 | |
| Drug | AGN 191659 | 1.19e-04 | 7 | 55 | 2 | CID006366726 | |
| Drug | AGN 190121 | 1.19e-04 | 7 | 55 | 2 | CID006441236 | |
| Drug | Vitamin A | 1.21e-04 | 200 | 55 | 5 | ctd:D014801 | |
| Drug | pyrazolanthrone | 1.24e-04 | 322 | 55 | 6 | ctd:C432165 | |
| Drug | E-guggulsterone | 1.36e-04 | 108 | 55 | 4 | CID006439929 | |
| Drug | HX 600 | 1.59e-04 | 8 | 55 | 2 | ctd:C104181 | |
| Drug | oxathiane | 1.59e-04 | 8 | 55 | 2 | CID000027596 | |
| Drug | rutamarin | 1.59e-04 | 8 | 55 | 2 | ctd:C022850 | |
| Drug | Flumazenil | 1.59e-04 | 8 | 55 | 2 | ctd:D005442 | |
| Drug | TTNN | 1.59e-04 | 8 | 55 | 2 | CID000135754 | |
| Drug | AC1O5JP6 | 1.59e-04 | 8 | 55 | 2 | CID006435379 | |
| Drug | CGP 36742 | 1.65e-04 | 44 | 55 | 3 | CID000130021 | |
| Drug | Ethchlorvynol | 2.04e-04 | 9 | 55 | 2 | DB00189 | |
| Drug | Steroids | 2.04e-04 | 9 | 55 | 2 | ctd:D013256 | |
| Drug | CNQX | 2.45e-04 | 126 | 55 | 4 | CID000002821 | |
| Drug | Secobarbital | 2.55e-04 | 10 | 55 | 2 | DB00418 | |
| Drug | Chlordiazepoxide | 2.55e-04 | 10 | 55 | 2 | DB00475 | |
| Drug | Metharbital | 2.55e-04 | 10 | 55 | 2 | DB00463 | |
| Drug | Pentobarbital | 2.55e-04 | 10 | 55 | 2 | DB00312 | |
| Drug | Talbutal | 2.55e-04 | 10 | 55 | 2 | DB00306 | |
| Drug | Clobazam | 2.55e-04 | 10 | 55 | 2 | DB00349 | |
| Drug | Butalbital | 2.55e-04 | 10 | 55 | 2 | DB00241 | |
| Drug | Butabarbital | 2.55e-04 | 10 | 55 | 2 | DB00237 | |
| Drug | Bromazepam | 2.55e-04 | 10 | 55 | 2 | DB01558 | |
| Drug | Barbituric acid derivative | 2.55e-04 | 10 | 55 | 2 | DB01496 | |
| Drug | Barbital | 2.55e-04 | 10 | 55 | 2 | DB01483 | |
| Drug | HX 630 | 2.55e-04 | 10 | 55 | 2 | ctd:C422175 | |
| Drug | Hexobarbital | 2.55e-04 | 10 | 55 | 2 | DB01355 | |
| Drug | Aprobarbital | 2.55e-04 | 10 | 55 | 2 | DB01352 | |
| Drug | Amobarbital | 2.55e-04 | 10 | 55 | 2 | DB01351 | |
| Drug | Heptabarbital | 2.55e-04 | 10 | 55 | 2 | DB01354 | |
| Drug | Butethal | 2.55e-04 | 10 | 55 | 2 | DB01353 | |
| Drug | Clonazepam | 2.55e-04 | 10 | 55 | 2 | DB01068 | |
| Drug | AC1L1FKW | 2.55e-04 | 10 | 55 | 2 | CID000003281 | |
| Drug | Methylphenobarbital | 2.55e-04 | 10 | 55 | 2 | DB00849 | |
| Drug | Oxazepam | 2.55e-04 | 10 | 55 | 2 | DB00842 | |
| Drug | Primidone | 2.55e-04 | 10 | 55 | 2 | DB00794 | |
| Drug | diazepinylbenzoic acid | 2.55e-04 | 10 | 55 | 2 | ctd:C438269 | |
| Drug | Midazolam | 2.55e-04 | 10 | 55 | 2 | DB00683 | |
| Drug | Flurazepam | 2.55e-04 | 10 | 55 | 2 | DB00690 | |
| Drug | flumazenil | 3.03e-04 | 54 | 55 | 3 | CID000003373 | |
| Drug | Thiopental | 3.11e-04 | 11 | 55 | 2 | DB00599 | |
| Drug | Alprazolam | 3.11e-04 | 11 | 55 | 2 | DB00404 | |
| Drug | fosazepam | 3.11e-04 | 11 | 55 | 2 | CID000037114 | |
| Drug | AGN 191701 | 3.11e-04 | 11 | 55 | 2 | CID006438168 | |
| Drug | C19H18ClN3O | 3.11e-04 | 11 | 55 | 2 | CID000027452 | |
| Drug | flutoprazepam | 3.11e-04 | 11 | 55 | 2 | CID000003400 | |
| Drug | Arfendazam | 3.11e-04 | 11 | 55 | 2 | CID000065803 | |
| Drug | Temazepam | 3.11e-04 | 11 | 55 | 2 | DB00231 | |
| Drug | Nitrazepam | 3.11e-04 | 11 | 55 | 2 | DB01595 | |
| Drug | Lorazepam | 3.11e-04 | 11 | 55 | 2 | DB00186 | |
| Drug | UVI 3003 | 3.11e-04 | 11 | 55 | 2 | ctd:C525131 | |
| Drug | Musk T | 3.11e-04 | 11 | 55 | 2 | CID000061014 | |
| Drug | camazepam | 3.11e-04 | 11 | 55 | 2 | CID000037367 | |
| Drug | Phenobarbital | 3.11e-04 | 11 | 55 | 2 | DB01174 | |
| Drug | triflubazam | 3.11e-04 | 11 | 55 | 2 | CID000031157 | |
| Drug | Bu-1014 | 3.11e-04 | 11 | 55 | 2 | CID015942721 | |
| Drug | Zapizolam | 3.11e-04 | 11 | 55 | 2 | CID000068832 | |
| Drug | Reclazepam | 3.11e-04 | 11 | 55 | 2 | CID003052777 | |
| Drug | iclazepam | 3.11e-04 | 11 | 55 | 2 | CID000068777 | |
| Drug | menitrazepam | 3.11e-04 | 11 | 55 | 2 | CID000189875 | |
| Drug | Triazolam | 3.11e-04 | 11 | 55 | 2 | DB00897 | |
| Drug | Serin hydrazid | 3.11e-04 | 11 | 55 | 2 | CID000041637 | |
| Drug | sulazepam | 3.11e-04 | 11 | 55 | 2 | CID000017931 | |
| Drug | elfazepam | 3.11e-04 | 11 | 55 | 2 | CID000065445 | |
| Drug | Clorazepate | 3.11e-04 | 11 | 55 | 2 | DB00628 | |
| Drug | uldazepam | 3.11e-04 | 11 | 55 | 2 | CID000034274 | |
| Drug | gidazepam | 3.11e-04 | 11 | 55 | 2 | CID000121919 | |
| Drug | fletazepam | 3.11e-04 | 11 | 55 | 2 | CID000036834 | |
| Drug | SB-205384 | 3.72e-04 | 12 | 55 | 2 | CID000197690 | |
| Drug | U-93631 | 3.72e-04 | 12 | 55 | 2 | CID000197626 | |
| Disease | Myocardial Preinfarction Syndrome | 1.02e-05 | 3 | 55 | 2 | C0086666 | |
| Disease | Angina, Unstable | 1.02e-05 | 3 | 55 | 2 | C0002965 | |
| Disease | chronic obstructive pulmonary disease (implicated_via_orthology) | 1.02e-05 | 3 | 55 | 2 | DOID:3083 (implicated_via_orthology) | |
| Disease | acute pancreatitis (implicated_via_orthology) | 3.40e-05 | 5 | 55 | 2 | DOID:2913 (implicated_via_orthology) | |
| Disease | pneumonia (implicated_via_orthology) | 1.52e-04 | 10 | 55 | 2 | DOID:552 (implicated_via_orthology) | |
| Disease | Rheumatoid Arthritis | 3.15e-04 | 174 | 55 | 4 | C0003873 | |
| Disease | amyotrophic lateral sclerosis, age at onset | 3.53e-04 | 15 | 55 | 2 | EFO_0004847, MONDO_0004976 | |
| Disease | alcohol dependence | 3.81e-04 | 183 | 55 | 4 | MONDO_0007079 | |
| Disease | Tremor, Rubral | 4.03e-04 | 16 | 55 | 2 | C0750940 | |
| Disease | Ataxia, Appendicular | 4.03e-04 | 16 | 55 | 2 | C0750937 | |
| Disease | Ataxia, Motor | 4.03e-04 | 16 | 55 | 2 | C0278161 | |
| Disease | Abnormal coordination | 4.03e-04 | 16 | 55 | 2 | C0520966 | |
| Disease | Ataxia, Truncal | 4.03e-04 | 16 | 55 | 2 | C0427190 | |
| Disease | Ataxia, Sensory | 4.03e-04 | 16 | 55 | 2 | C0240991 | |
| Disease | Metabolic Syndrome X | 7.00e-04 | 21 | 55 | 2 | C0524620 | |
| Disease | eye morphology measurement | 7.36e-04 | 218 | 55 | 4 | EFO_0007858 | |
| Disease | chronic obstructive pulmonary disease (is_marker_for) | 7.98e-04 | 97 | 55 | 3 | DOID:3083 (is_marker_for) | |
| Disease | sciatic neuropathy (biomarker_via_orthology) | 8.47e-04 | 99 | 55 | 3 | DOID:11446 (biomarker_via_orthology) | |
| Disease | Ataxia | 9.96e-04 | 25 | 55 | 2 | C0004134 | |
| Disease | blood nickel measurement | 1.48e-03 | 120 | 55 | 3 | EFO_0007583 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HPKGYAYIEFATKGS | 186 | A6NDY0 | |
| NYKHCFSYAIGKPGD | 831 | Q5SY80 | |
| FTCKGKPVYHFFGTS | 136 | P08319 | |
| STGKFHCNIPGLYYF | 146 | Q15848 | |
| SLPGHFSSHYKKFFC | 306 | Q9Y6B7 | |
| SPYACFYGASAKKVK | 471 | Q8WZ64 | |
| SFGSRLGCNYYHKPS | 236 | P08217 | |
| AYRKLCPHGSGYTAE | 2346 | Q75N90 | |
| DRFSGKKYHFFYGCG | 471 | Q9BYV7 | |
| HGYCSPTSASYGKAL | 56 | P56178 | |
| HYYGGSAAKFAPSPA | 11 | Q8NB25 | |
| AKYSELGHPFGYLKA | 356 | Q9UL03 | |
| RYPSNKGIYLCGHSA | 151 | Q63HM1 | |
| PYSGCGKVYGKSSHL | 146 | Q13886 | |
| KDCKHPNIVAYFGSY | 66 | Q8IVH8 | |
| PRLGHSFSLYGNKCY | 126 | Q9Y5Z7 | |
| NGTLKYHFYCPGEAK | 1941 | Q5T1H1 | |
| LGSYAALHGEFYCKP | 76 | Q9BT23 | |
| PVHGADGKFYTNKCY | 936 | Q9NQ38 | |
| FKNYGAEKYGPHSVC | 511 | Q96KR4 | |
| HFFKLKSACGEPAYT | 536 | Q6L8Q7 | |
| DAHACPLKFGSYAYT | 176 | P14867 | |
| MDGHACPLKFGSYAY | 181 | P48169 | |
| FGRCHAAVKPGTYYS | 641 | P98088 | |
| SVGKPHKCGYCGRSY | 196 | Q13422 | |
| SFCKYKCKPGYHVPG | 1371 | Q13219 | |
| HLGGYYFIGCKPDST | 656 | Q8N475 | |
| STATGDGKHYCYPHF | 336 | P38405 | |
| LYHCPLYKTGARAGT | 4106 | Q9C0G6 | |
| AYPAFACGSGYVISK | 406 | Q8NCR0 | |
| HFGRQCKLAYYGFTK | 1291 | Q9Y4F3 | |
| CHGDASKFYGYEALP | 81 | P31273 | |
| GTSYKCLCDPGYHGL | 486 | Q8NFT8 | |
| HYGVYSCEGCKGFFK | 146 | P19793 | |
| PKGSKAYGSPCYALF | 41 | Q6UW15 | |
| GFPDKKHKLYGVYCF | 336 | P10915 | |
| GHAKITCGYDLPAKY | 126 | A1Z1Q3 | |
| PKGSKAYGSHCYALF | 41 | Q06141 | |
| AYGSHCYALFLSPKS | 46 | Q06141 | |
| KSKTCYEGNGHFYRG | 66 | P00749 | |
| AYHLQKSTCGKCGYP | 26 | P61927 | |
| TKYANFSEGACKPGY | 76 | Q11203 | |
| YFSAKSGVYCGPLKL | 221 | Q8IYB8 | |
| HYGVYSCEGCKGFFK | 216 | P28702 | |
| HYIGKYKCDCPPGFS | 636 | Q8TER0 | |
| GTYYCVKFRKGSPDH | 116 | Q5TFQ8 | |
| ECAFGKIYKGHLYLP | 481 | Q01973 | |
| AYLPGSYGSSHCKLE | 171 | O60248 | |
| CYSPKGGNYHSSLGT | 71 | O60687 | |
| HSPGFYTGKPGYKLC | 376 | Q9Y4K3 | |
| EGSDGKKHPYYYSCH | 886 | Q17R98 | |
| CAAPFASHFLYKAGG | 136 | Q6ZP80 | |
| HCGKPYRSKAGLAYH | 291 | Q96ME7 | |
| SCGKAFATGYGLKSH | 201 | P36508 | |
| KPYQCHECGKTFSYG | 556 | Q99676 | |
| GHFGKVSLYCYDPTN | 906 | P29597 |